Drug Approval | July 10, 2024
Lupin receives tentative approval from USFDA for Empagliflozin, Linagliptin and Metformin Hydrochloride ER tablets
This product will be manufactured at Lupin’s Pithampur facility in India
This product will be manufactured at Lupin’s Pithampur facility in India
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Shares and American Depositary Shares of Olink for $26.00 per Share
AIIMS Jammu is a beacon of hope not only for the people of J&K, but also for that of Leh, and other neighboring states
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
Subscribe To Our Newsletter & Stay Updated
